Clinical Trial Update: A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte [Phase 3]

View source ↗

Summary

Phase 3 bioequivalence study completed comparing a Tobramycin and Prednisolone Acetate ophthalmic formulation with PredForte for eye infections and related post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eye Infection
• Postoperative Ocular Complications

Drugs mentioned

• PredForte (prednisolone acetate)
• Tobramycin and Prednisolone Acetate ophthalmic suspension (tobramycin; prednisolone acetate)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Eye Infections, Postoperative Complications | Phase 3 | Status: COMPLETED